Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7707560

CN(C)C1CCCCC1.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
ADH1C P00326 1/20 0.39
ADH1A P07327 1/20 0.39
ATM Q13315 1/20 0.38
RAB9A P51151 2/20 0.37
POLB P06746 1/20 0.37
HSD11B1 P28845 1/20 0.36
FAAH O00519 1/20 0.35
PHGDH O43175 1/20 0.35
MGLL Q99685 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
RECQL P46063 1/20 0.34
PDK1 Q15118 1/20 0.34
PDK2 Q15119 1/20 0.34
PDK3 Q15120 1/20 0.34
PDK4 Q16654 1/20 0.34
L3MBTL3 Q96JM7 1/20 0.34
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL1817809 0.84 ADH1A (0.46) ALDH1A1ADH1CADH1AATMFAAH
Trifluoroacetic Acid SCHEMBL31419183 0.84 ALDH1A1 (0.38) ALDH1A1ADH1CADH1AATMRAB9A
Acetic Acid SCHEMBL1515874 0.82 ADH1C (0.44) ALDH1A1ADH1CADH1AATMFAAH
Carbamic Acid SCHEMBL30426519 0.80 ALDH1A1 (0.43) ALDH1A1ADH1CADH1AATMFAAH
Trifluoroacetic Acid SCHEMBL5443972 0.80 GABRP (0.39) TSHRHRH4HRH3
Trifluoroacetic Acid SCHEMBL7446778 0.80 GABRP (0.39) TSHRHRH4HRH3
Trifluoroacetic Acid SCHEMBL5443966 0.80 GABRP (0.39) TSHRHRH4HRH3
Trifluoroacetic Acid SCHEMBL3416241 0.78 ALDH1A1 (0.41) ALDH1A1ATMRAB9APOLBFAAH
Trifluoroacetic Acid SCHEMBL34473342 0.78 SLC6A1 (0.42) ATMKDM4EKMT2ATSHR
Oxalic Acid SCHEMBL28457781 0.77 L3MBTL3 (0.41) ALDH1A1ADH1CADH1AATMPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6361940-B1 IMMOBILIZATION; GENETIC ENGINEERING QIAGEN GENOMICS, INC. 2002-03-26 US claimed
US-20250066860-A1 METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK 2025-02-27 US disclosed
US-12195803-B2 Methods and materials for assessing and treating cancer THE JOHNS HOPKINS UNIVERSITY (US) 2025-01-14 US disclosed
US-20200377956-A1 METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER THE JOHNS HOPKINS UNIVERSITY 2020-12-03 US disclosed
EP-3665308-A1 METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER The Johns Hopkins University (US) 2020-06-17 EP disclosed
US-20190256924-A1 METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER THE JOHNS HOPKINS UNIVERSITY 2019-08-22 US disclosed
WO-2019067092-A1 METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER THE JOHNS HOPKINS UNIVERSITY (US) 2019-04-04 WO disclosed
EP-2758377-A1 CYCLOALKYLNITRILE PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2014-07-30 EP disclosed
WO-2013040863-A1 CYCLOALKYLNITRILE PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2013-03-28 WO disclosed
US-6361940-B1 IMMOBILIZATION; GENETIC ENGINEERING QIAGEN GENOMICS, INC. 2002-03-26 US disclosed
EP-0958378-A2 COMPOSITIONS AND METHODS FOR ENHANCING HYBRIDIZATION SPECIFICITY Rapigene, Inc. (US) 1999-11-24 EP disclosed
EP-0952228-A2 Compositions and methods for enhancing hybridization specificity Rapigene, Inc. (US) 1999-10-27 EP disclosed
WO-1998013527-A2 COMPOSITIONS AND METHODS FOR ENHANCING HYBRIDIZATION SPECIFICITY RAPIGENE, INC. (US) 1998-04-02 WO disclosed